Literature DB >> 19392863

Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

A Singal1, M L Volk, A Waljee, R Salgia, P Higgins, M A M Rogers, J A Marrero.   

Abstract

BACKGROUND: A majority of studies investigating the accuracy of ultrasound for detecting hepatocellular carcinoma (HCC) do not reflect how this test is used for surveillance vs. diagnosis. AIM: To determine the performance characteristics of surveillance with ultrasound for the detection of HCC, particularly early HCC as defined by the Milan criteria.
METHODS: A systematic literature review using the MEDLINE and SCOPUS databases yielded six studies that evaluated the accuracy of ultrasound for HCC at any stage and 13 studies that were specific to early HCC.
RESULTS: Surveillance ultrasound detected the majority of tumours before they presented clinically, with a pooled sensitivity of 94%. However, ultrasound was less effective for detecting early HCC with a sensitivity of 63%. Alpha-fetoprotein provided no additional benefit to ultrasound. Meta-regression analysis demonstrated a significantly higher sensitivity for early HCC with ultrasound every 6 months than with annual surveillance. Current studies have limitations such as verification bias and are of suboptimal quality.
CONCLUSIONS: Surveillance with ultrasound demonstrates limited sensitivity for early HCC, although this may be improved by testing at 6-month intervals. Currently available evidence evaluating surveillance ultrasound has significant limitations and future studies are necessary to determine optimal surveillance methods for early HCC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19392863      PMCID: PMC6871653          DOI: 10.1111/j.1365-2036.2009.04014.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  46 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Application of summary receiver operating characteristics (sROC) analysis to diagnostic clinical testing.

Authors:  A S Rosman; M A Korsten
Journal:  Adv Med Sci       Date:  2007       Impact factor: 3.287

3.  Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

Authors:  L Bolondi; S Sofia; S Siringo; S Gaiani; A Casali; G Zironi; F Piscaglia; L Gramantieri; M Zanetti; M Sherman
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

4.  Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort.

Authors:  Jorge A Marrero; Robert J Fontana; Ashley Barrat; Frederick Askari; Hari S Conjeevaram; Grace L Su; Anna S Lok
Journal:  Hepatology       Date:  2005-04       Impact factor: 17.425

Review 5.  Issues in screening and surveillance for hepatocellular carcinoma.

Authors:  Adrian M Di Bisceglie
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

6.  Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma.

Authors:  Eugenio Caturelli; Francesca Bartolucci; Elisabetta Biasini; Maria Luigia Vigliotti; Angelo Andriulli; Domenico Angelo Siena; Vito Attino; Michele Bisceglia
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

7.  Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.

Authors:  Jorge A Marrero; Grace L Su; Wei Wei; Dawn Emick; Hari S Conjeevaram; Robert J Fontana; Anna S Lok
Journal:  Hepatology       Date:  2003-05       Impact factor: 17.425

Review 8.  Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.

Authors:  Samir Gupta; Stephen Bent; Jeffrey Kohlwes
Journal:  Ann Intern Med       Date:  2003-07-01       Impact factor: 25.391

9.  Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis.

Authors:  D Pateron; N Ganne; J C Trinchet; M H Aurousseau; F Mal; C Meicler; E Coderc; P Reboullet; M Beaugrand
Journal:  J Hepatol       Date:  1994-01       Impact factor: 25.083

10.  Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives.

Authors:  David K Espey; Xiao-Cheng Wu; Judith Swan; Charles Wiggins; Melissa A Jim; Elizabeth Ward; Phyllis A Wingo; Holly L Howe; Lynn A G Ries; Barry A Miller; Ahmedin Jemal; Faruque Ahmed; Nathaniel Cobb; Judith S Kaur; Brenda K Edwards
Journal:  Cancer       Date:  2007-11-15       Impact factor: 6.860

View more
  238 in total

1.  Surveillance for Hepatocellular Carcinoma: Does the Place Where Ultrasound Is Performed Impact Its Effectiveness?

Authors:  Federico Piñero; Fernando Rubinstein; Sebastián Marciano; Nora Fernández; Jorge Silva; Yanina Zambelo; Margarita Anders; Alina Zerega; Ezequiel Ridruejo; Carlos Miguez; Beatriz Ameigeiras; Claudia D'Amico; Luis Gaite; Carla Bermúdez; Carlos Rosales; Gustavo Romero; Lucas McCormack; Virginia Reggiardo; Luis Colombato; Adrián Gadano; Marcelo Silva
Journal:  Dig Dis Sci       Date:  2018-12-03       Impact factor: 3.199

2.  Trend of improving prognosis of hepatocellular carcinoma in clinical practice: an Italian in-field experience.

Authors:  Mauro Borzio; Elena Dionigi; Angelo Rossini; Anna Toldi; Giampiero Francica; Fabio Fornari; Andrea Salmi; Fabio Farinati; Susanna Vicari; Massimo Marignani; Fulvia Terracciano; Barbara Ginanni; Rodolfo Sacco
Journal:  Dig Dis Sci       Date:  2014-11-16       Impact factor: 3.199

3.  Predictors of liver transplant eligibility for patients with hepatocellular carcinoma in a safety net hospital.

Authors:  Amit G Singal; Vincent Chan; Yonas Getachew; Richard Guerrero; Joan S Reisch; Jennifer A Cuthbert
Journal:  Dig Dis Sci       Date:  2011-09-28       Impact factor: 3.199

4.  Hepatobiliary quiz-5 (2013).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2013-03

Review 5.  Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis.

Authors:  Kerstin Schütte; Christian Schulz; Alexander Link; Peter Malfertheiner
Journal:  World J Hepatol       Date:  2015-02-27

6.  Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma.

Authors:  Amit G Singal; Akbar K Waljee; Nishant Patel; Emerson Y Chen; Jasmin A Tiro; Jorge A Marrero; Adam C Yopp
Journal:  J Natl Compr Canc Netw       Date:  2013-09-01       Impact factor: 11.908

Review 7.  Quality improvement in gastroenterology clinical practice.

Authors:  Rakhi Kheraj; Sumeet K Tewani; Gyanprakash Ketwaroo; Daniel A Leffler
Journal:  Clin Gastroenterol Hepatol       Date:  2012-08-16       Impact factor: 11.382

Review 8.  Role of US LI-RADS in the LI-RADS Algorithm.

Authors:  Shuchi K Rodgers; David T Fetzer; Helena Gabriel; James H Seow; Hailey H Choi; Katherine E Maturen; Ashish P Wasnik; Tara A Morgan; Nirvikar Dahiya; Mary K O'Boyle; Yuko Kono; Claude B Sirlin; Aya Kamaya
Journal:  Radiographics       Date:  2019 May-Jun       Impact factor: 5.333

9.  2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

10.  Factors that affect accuracy of α-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis.

Authors:  Purva Gopal; Adam C Yopp; Akbar K Waljee; Jason Chiang; Mahendra Nehra; Pragathi Kandunoori; Amit G Singal
Journal:  Clin Gastroenterol Hepatol       Date:  2013-10-02       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.